News

Video

The future of Glaucoma 360: Residents and retina

Andrew Iwach, MD, co-founder of the Glaucoma 360 meeting shares that value this meeting has for residents and fellows as they embark on their careers and the future additions to the meeting that will include retina discussions.

The continuation of this interview with Andrew Iwach, MD, a co-founder of the Glaucoma 360 conference encourages residents to attend the meeting as the event is a valuable learning experience as they develop their understanding of glaucoma and can stand at the forefront of innovation in this field or research and development. The meeting serves as both an educational platform and a fundraising event for a non-profit organization.

Iwach emphasizes the importance of user-friendly and practical approaches in the scientific community. They note that the typical process from idea to peer-reviewed publication can take 3-5 years, which the Glaucoma 360 event aims to address by being ahead of the curve. He also shares his personal experience of consistently learning new things by attending the annual meeting over the past 28 years.

Another key aspect of the event is the intersection between glaucoma and retina. For the past 10 years, the meeting has included a lecture by retinal specialists, and in 2026 the organizers will be adding a half-day program specifically focused on retina. This new "Glaucoma 360 Plus" program will be led by retina specialists J. Michael Jumper, MD and Gaurav K. Shah, MD, FASRS.

The website for the event is currently open for registration, and Iwach encourages early registration for the 2026 CME programs. The ongoing commitment to this annual event demonstrates its importance as a platform for learning, collaboration, and advancing the field of glaucoma. Overall, the interview highlights the Glaucoma 360 event as a unique and valuable opportunity for residents, fellows, and clinicians to engage with the latest developments, research, and best practices in glaucoma and related specialties.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
Alex Hacopian, MD, discusses a presbyopia-correcting IOL at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
Brett Bielory, MD, discusses his poster at the ASCRS annual meeting, which focuses on an under-diagnosed corneal pathology: neurotrophic keratitis.
(Image credit: Ophthalmology Times) Oluwatosin U. Smith talks Glaukomtecken
ASCRS 2025: Eva Kim, MD, discusses implantable collamer lenses and high myopia.
Abby Markward, MBA, and Hattie Hayes, editor of Ophthalmology Times Europe, discuss the ASCRS and ASOA meetings
© 2025 MJH Life Sciences

All rights reserved.